HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Benjamin Deroure Selected Research

Thrombotic Thrombocytopenic Purpura

9/2005Efficiency of curative and prophylactic treatment with rituximab in ADAMTS13-deficient thrombotic thrombocytopenic purpura: a study of 11 cases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Benjamin Deroure Research Topics

Disease

1Acute Kidney Injury (Acute Renal Failure)
06/2010
1Kidney Diseases (Kidney Disease)
09/2008
1Non-Hodgkin Lymphoma (Lymphosarcoma)
09/2008
1Necrosis
09/2008
1Nephrotic Syndrome (Syndrome, Nephrotic)
09/2008
1Multiple Myeloma
09/2008
1Amyloidosis
09/2008
1Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II)
09/2008
1Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
09/2008
1Thrombotic Thrombocytopenic Purpura
09/2005

Drug/Important Bio-Agent (IBA)

1Immunoglobulin M (IgM)IBA
09/2008
1Rituximab (Mabthera)FDA Link
09/2005
1thiamine triphosphorate (TTP)IBA
09/2005

Therapy/Procedure

1Transplantation
06/2010
1Drug Therapy (Chemotherapy)
09/2008